Jing Yang
Zhengzhou University · 76 works · 2,640 citations · h-index 24
Top works
- Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
- Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
- Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results
- A Comparison Study of Machine Learning (Random Survival Forest) and Classic Statistic (Cox Proportional Hazards) for Predicting Progression in High-Grade Glioma after Proton and Carbon Ion Radiotherapy
- First‐line epidermal growth factor receptor ( EGFR )–tyrosine kinase inhibitor alone or with whole‐brain radiotherapy for brain metastases in patients with EGFR ‐mutated lung adenocarcinoma
- Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
- Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution
- The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine
- Myeloid sarcoma derived from the gastrointestinal tract: A case report and review of the literature
- Development of a method for the detection of Cu2+ in the environment and live cells using a synthesized spider web-like fluorescent probe
- Final analysis of KEYNOTE-189: Pemetrexed-platinum chemotherapy (chemo) with or without pembrolizumab (pembro) in patients (pts) with previously untreated metastatic nonsquamous non-small cell lung cancer (NSCLC).
- Health-related quality of life (HRQoL) in the KEYNOTE-189 study of pembrolizumab (pembro) or placebo (pbo) + pemetrexed (pem) + platinum (plt) for metastatic NSCLC.
- Design, synthesis and biological activity of novel donepezil derivatives bearing N -benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors
- A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
- Abstract CT043: Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed-platinum: Results from the KEYNOTE-189 study
- Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial
- Outcomes of orbital malignancies treated with eye-sparing surgery and adjuvant particle radiotherapy: a retrospective study
- Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies
- Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck
- Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world